The estimated Net Worth of Chad Thomas Campbell is at least $1.6 Milion dollars as of 17 July 2024. Mr. Campbell owns over 6,600 units of Angiodynamic Inc stock worth over $520,788 and over the last 7 years he sold ANGO stock worth over $0. In addition, he makes $1,078,290 as Senior Vice President and General Manager i Vascular Access at Angiodynamic Inc.
Chad has made over 6 trades of the Angiodynamic Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 6,600 units of ANGO stock worth $48,972 on 17 July 2024.
The largest trade he's ever made was exercising 10,748 units of Angiodynamic Inc stock on 5 October 2021 worth over $178,309. On average, Chad trades about 997 units every 61 days since 2017. As of 17 July 2024 he still owns at least 70,187 units of Angiodynamic Inc stock.
You can see the complete history of Mr. Campbell stock trades at the bottom of the page.
Chad T. Campbell serves as Senior Vice President and General Manager, Vascular Access of the Company. He joined AngioDynamics in May 2016 as the Senior Vice President and General Manager for the Vascular Access Global Business Unit. In his role, Mr. Campbell oversees research and development and global commercialization of the Global Business Unit’s portfolio. Mr. Campbell joined AngioDynamics from Medtronic where he served as the Vice President of Marketing for the Patient Care and Safety business after serving as the Vice President of Marketing for the SharpSafety business at Covidien (Medtronic). During his tenure at Covidien, Mr. Campbell also held roles including Director of Marketing, Area Vice President of Sales, Region Manager, Product Manager and Account Manager. Mr. Campbell received a Bachelor of Arts from the University of Kentucky.
As the Senior Vice President and General Manager i Vascular Access of Angiodynamic Inc, the total compensation of Chad Campbell at Angiodynamic Inc is $1,078,290. There are 2 executives at Angiodynamic Inc getting paid more, with James Clemmer having the highest compensation of $3,116,630.
Chad Campbell is 49, he's been the Senior Vice President and General Manager i Vascular Access of Angiodynamic Inc since 2016. There are 22 older and 4 younger executives at Angiodynamic Inc. The oldest executive at Angiodynamic Inc is Dennis Meteny, 67, who is the Independent Director.
Chad's mailing address filed with the SEC is 14 PLAZA DRIVE, , LATHAM, NY, 12110.
Over the last 20 years, insiders at Angiodynamic Inc have traded over $207,843,757 worth of Angiodynamic Inc stock and bought 255,612 units worth $3,086,102 . The most active insiders traders include David F Burgstahler, Sriram Venkataraman oraz Capital Partners Gp, Llc Av.... On average, Angiodynamic Inc executives and independent directors trade stock every 36 days with the average trade being worth of $826,492. The most recent stock trade was executed by Laura Piccinini on 17 July 2024, trading 4,439 units of ANGO stock currently worth $32,937.
founded in 1988 in queensbury, n.y., u.s., angiodynamics is today a nasdaq-listed public company. we are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. our diverse product line includes market-leading radiofrequency ablation and nanoknife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. angiodynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. angiodynamics believes it is well poised to continue that trend. looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patie
Angiodynamic Inc executives and other stock owners filed with the SEC include: